chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure increased, Bradycardia, COVID-19, Condition aggravated
Clinical narrative: On 01/17/22 pt was diagnosed with  COVID-19 infection and receive Paxlovid,.  He presented to the ER, he appeared very weak and dehydrated in the ER.  Unable to provide history.   Per MMR patient was seen bradycardic in the 40s received 1 mg of atropine with significant improvement in his heart rate. He is doing well on room air.  His stay was complicated by some episodes of hypoxia he required Decadron medication for short while.    PT/OT recommending post acute screen.  Bradycardia resolved after Lopressor was discontinued.  Psych consulted to adjust psychotropic medication, no changes made at this time.  Patient will need outpatient event monitor to evaluate for bradycardia.  Paxlovid has not been known to cause bradycardia.  Outpatient event monitor recommended at discharge.  His stay was complicated by severely elevated blood pressures his medications were up titrated relatively stable at this time would recommend close monitoring of his blood pressures while at the rehab facility.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dehydration, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: On 01/17/22 pt was diagnosed with  COVID-19 infection and receive Paxlovid,.  He presented to the ER, he appeared very weak and dehydrated in the ER.  Unable to provide history.   Per MMR patient was seen bradycardic in the 40s received 1 mg of atropine with significant improvement in his heart rate. He is doing well on room air.  His stay was complicated by some episodes of hypoxia he required Decadron medication for short while.    PT/OT recommending post acute screen.  Bradycardia resolved after Lopressor was discontinued.  Psych consulted to adjust psychotropic medication, no changes made at this time.  Patient will need outpatient event monitor to evaluate for bradycardia.  Paxlovid has not been known to cause bradycardia.  Outpatient event monitor recommended at discharge.  His stay was complicated by severely elevated blood pressures his medications were up titrated relatively stable at this time would recommend close monitoring of his blood pressures while at the rehab facility.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Agitation, Animal scratch, Anticoagulant therapy, Atrial fibrillation, Bacteraemia
Clinical narrative: Patient was recently hospitalized for a septic shock secondary to UTI with Klebsiella and myroides bacteremia likely cat scratch and discharged home on ciprofloxacin.  Patient return to the ER on 01/17 for altered mental status and found to be hypoxic.  CT head revealed small area of ischemia and internal capsule could be artifactual.  COVID test was positive. Patient admitted and continued to be obtunded and hypotensive and was intubated and started on with active support.  Patient was admitted to ICU and started on bicarb infusion and broad-spectrum antimicrobials.  On 01/19 patient self extubated and tolerated it well.  Patient was transferred out of ICU on 01/20/2022 and continued to have behavioral issues,  psych was consulted with no intervention,  likely it acute metabolic encephalopathy due to medical conditions.  Patient also developed RVR with AFib and cardiology was consulted and started patient on amio drip and warfarin  and was rate controlled.   Patient had acute drop of hemoglobin and given 1 unit PRBC, due to episodes of black stools GI consulted and warfarin was held.   Patient underwent EGD on 01/23/2022, which did not show any active bleed. Pt discharged on Levaquin for two more days to complete 5 days course. Pt also discharged with seven day course of dexamethasone 1mg and amiodarone 400po bid X7 days followed by 200mg po daily along with warfarin. Psych was on consult, d/ced Zyprexa and Cymbalta, agitation much improved but somnolent. Pt discharged home with HHC in stable condition.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Behaviour disorder, COVID-19, Cerebral ischaemia, Computerised tomogram head abnormal, Depressed level of consciousness
Clinical narrative: Patient was recently hospitalized for a septic shock secondary to UTI with Klebsiella and myroides bacteremia likely cat scratch and discharged home on ciprofloxacin.  Patient return to the ER on 01/17 for altered mental status and found to be hypoxic.  CT head revealed small area of ischemia and internal capsule could be artifactual.  COVID test was positive. Patient admitted and continued to be obtunded and hypotensive and was intubated and started on with active support.  Patient was admitted to ICU and started on bicarb infusion and broad-spectrum antimicrobials.  On 01/19 patient self extubated and tolerated it well.  Patient was transferred out of ICU on 01/20/2022 and continued to have behavioral issues,  psych was consulted with no intervention,  likely it acute metabolic encephalopathy due to medical conditions.  Patient also developed RVR with AFib and cardiology was consulted and started patient on amio drip and warfarin  and was rate controlled.   Patient had acute drop of hemoglobin and given 1 unit PRBC, due to episodes of black stools GI consulted and warfarin was held.   Patient underwent EGD on 01/23/2022, which did not show any active bleed. Pt discharged on Levaquin for two more days to complete 5 days course. Pt also discharged with seven day course of dexamethasone 1mg and amiodarone 400po bid X7 days followed by 200mg po daily along with warfarin. Psych was on consult, d/ced Zyprexa and Cymbalta, agitation much improved but somnolent. Pt discharged home with HHC in stable condition.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Endotracheal intubation, Extubation, Faeces discoloured, Haemoglobin decreased, Hypotension
Clinical narrative: Patient was recently hospitalized for a septic shock secondary to UTI with Klebsiella and myroides bacteremia likely cat scratch and discharged home on ciprofloxacin.  Patient return to the ER on 01/17 for altered mental status and found to be hypoxic.  CT head revealed small area of ischemia and internal capsule could be artifactual.  COVID test was positive. Patient admitted and continued to be obtunded and hypotensive and was intubated and started on with active support.  Patient was admitted to ICU and started on bicarb infusion and broad-spectrum antimicrobials.  On 01/19 patient self extubated and tolerated it well.  Patient was transferred out of ICU on 01/20/2022 and continued to have behavioral issues,  psych was consulted with no intervention,  likely it acute metabolic encephalopathy due to medical conditions.  Patient also developed RVR with AFib and cardiology was consulted and started patient on amio drip and warfarin  and was rate controlled.   Patient had acute drop of hemoglobin and given 1 unit PRBC, due to episodes of black stools GI consulted and warfarin was held.   Patient underwent EGD on 01/23/2022, which did not show any active bleed. Pt discharged on Levaquin for two more days to complete 5 days course. Pt also discharged with seven day course of dexamethasone 1mg and amiodarone 400po bid X7 days followed by 200mg po daily along with warfarin. Psych was on consult, d/ced Zyprexa and Cymbalta, agitation much improved but somnolent. Pt discharged home with HHC in stable condition.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Infusion, Intensive care, Intentional medical device removal by patient, Klebsiella infection
Clinical narrative: Patient was recently hospitalized for a septic shock secondary to UTI with Klebsiella and myroides bacteremia likely cat scratch and discharged home on ciprofloxacin.  Patient return to the ER on 01/17 for altered mental status and found to be hypoxic.  CT head revealed small area of ischemia and internal capsule could be artifactual.  COVID test was positive. Patient admitted and continued to be obtunded and hypotensive and was intubated and started on with active support.  Patient was admitted to ICU and started on bicarb infusion and broad-spectrum antimicrobials.  On 01/19 patient self extubated and tolerated it well.  Patient was transferred out of ICU on 01/20/2022 and continued to have behavioral issues,  psych was consulted with no intervention,  likely it acute metabolic encephalopathy due to medical conditions.  Patient also developed RVR with AFib and cardiology was consulted and started patient on amio drip and warfarin  and was rate controlled.   Patient had acute drop of hemoglobin and given 1 unit PRBC, due to episodes of black stools GI consulted and warfarin was held.   Patient underwent EGD on 01/23/2022, which did not show any active bleed. Pt discharged on Levaquin for two more days to complete 5 days course. Pt also discharged with seven day course of dexamethasone 1mg and amiodarone 400po bid X7 days followed by 200mg po daily along with warfarin. Psych was on consult, d/ced Zyprexa and Cymbalta, agitation much improved but somnolent. Pt discharged home with HHC in stable condition.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Mental status changes, Metabolic encephalopathy, Oesophagogastroduodenoscopy normal, Red blood cell transfusion, SARS-CoV-2 test positive
Clinical narrative: Patient was recently hospitalized for a septic shock secondary to UTI with Klebsiella and myroides bacteremia likely cat scratch and discharged home on ciprofloxacin.  Patient return to the ER on 01/17 for altered mental status and found to be hypoxic.  CT head revealed small area of ischemia and internal capsule could be artifactual.  COVID test was positive. Patient admitted and continued to be obtunded and hypotensive and was intubated and started on with active support.  Patient was admitted to ICU and started on bicarb infusion and broad-spectrum antimicrobials.  On 01/19 patient self extubated and tolerated it well.  Patient was transferred out of ICU on 01/20/2022 and continued to have behavioral issues,  psych was consulted with no intervention,  likely it acute metabolic encephalopathy due to medical conditions.  Patient also developed RVR with AFib and cardiology was consulted and started patient on amio drip and warfarin  and was rate controlled.   Patient had acute drop of hemoglobin and given 1 unit PRBC, due to episodes of black stools GI consulted and warfarin was held.   Patient underwent EGD on 01/23/2022, which did not show any active bleed. Pt discharged on Levaquin for two more days to complete 5 days course. Pt also discharged with seven day course of dexamethasone 1mg and amiodarone 400po bid X7 days followed by 200mg po daily along with warfarin. Psych was on consult, d/ced Zyprexa and Cymbalta, agitation much improved but somnolent. Pt discharged home with HHC in stable condition.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Septic shock, Somnolence, Urinary tract infection
Clinical narrative: Patient was recently hospitalized for a septic shock secondary to UTI with Klebsiella and myroides bacteremia likely cat scratch and discharged home on ciprofloxacin.  Patient return to the ER on 01/17 for altered mental status and found to be hypoxic.  CT head revealed small area of ischemia and internal capsule could be artifactual.  COVID test was positive. Patient admitted and continued to be obtunded and hypotensive and was intubated and started on with active support.  Patient was admitted to ICU and started on bicarb infusion and broad-spectrum antimicrobials.  On 01/19 patient self extubated and tolerated it well.  Patient was transferred out of ICU on 01/20/2022 and continued to have behavioral issues,  psych was consulted with no intervention,  likely it acute metabolic encephalopathy due to medical conditions.  Patient also developed RVR with AFib and cardiology was consulted and started patient on amio drip and warfarin  and was rate controlled.   Patient had acute drop of hemoglobin and given 1 unit PRBC, due to episodes of black stools GI consulted and warfarin was held.   Patient underwent EGD on 01/23/2022, which did not show any active bleed. Pt discharged on Levaquin for two more days to complete 5 days course. Pt also discharged with seven day course of dexamethasone 1mg and amiodarone 400po bid X7 days followed by 200mg po daily along with warfarin. Psych was on consult, d/ced Zyprexa and Cymbalta, agitation much improved but somnolent. Pt discharged home with HHC in stable condition.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Blood creatinine increased, C-reactive protein increased, COVID-19
Clinical narrative: Pt presents to the ED for fever and urinary frequency.  Symptoms have been going on for the past couple days.  She has also noticed shortness of breath and has required 4 L of oxygen in the ED.  Initial vital signs showed oxygen saturation of 85% on room air, T-max of a 100.2°.  Labs, WBC 7.05, creatinine of 2.2, CRP 13.7, D-dimer 620.  Virology - positive COVID-19.  UA was positive for urinary tract infection. Pt was diagnosed with acute hypoxic respiratory failure secondary to COVID-19. dexamethasone, vitamin-D, vitamin-C, respiratory care protocol oxygen as needed.  Ciprofloxacin was started for urinary tract infection pending urine cultures.  Rest of home medications reviewed and restarted.  Avoid any nephrotoxic agents.  Metformin held due to acute kidney injury gentle IV hydration.   She initially required high-flow nasal cannula and was able to taper back to nasal cannula.  CPAP continued for OSA. She has completed Remdesivir.  She is on a Decadron wean at time of discharge.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Culture urine, Dyspnoea, Fibrin D dimer, Laboratory test
Clinical narrative: Pt presents to the ED for fever and urinary frequency.  Symptoms have been going on for the past couple days.  She has also noticed shortness of breath and has required 4 L of oxygen in the ED.  Initial vital signs showed oxygen saturation of 85% on room air, T-max of a 100.2°.  Labs, WBC 7.05, creatinine of 2.2, CRP 13.7, D-dimer 620.  Virology - positive COVID-19.  UA was positive for urinary tract infection. Pt was diagnosed with acute hypoxic respiratory failure secondary to COVID-19. dexamethasone, vitamin-D, vitamin-C, respiratory care protocol oxygen as needed.  Ciprofloxacin was started for urinary tract infection pending urine cultures.  Rest of home medications reviewed and restarted.  Avoid any nephrotoxic agents.  Metformin held due to acute kidney injury gentle IV hydration.   She initially required high-flow nasal cannula and was able to taper back to nasal cannula.  CPAP continued for OSA. She has completed Remdesivir.  She is on a Decadron wean at time of discharge.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Lung infiltration, Obstructive sleep apnoea syndrome, Pollakiuria, Positive airway pressure therapy, Pyrexia
Clinical narrative: Pt presents to the ED for fever and urinary frequency.  Symptoms have been going on for the past couple days.  She has also noticed shortness of breath and has required 4 L of oxygen in the ED.  Initial vital signs showed oxygen saturation of 85% on room air, T-max of a 100.2°.  Labs, WBC 7.05, creatinine of 2.2, CRP 13.7, D-dimer 620.  Virology - positive COVID-19.  UA was positive for urinary tract infection. Pt was diagnosed with acute hypoxic respiratory failure secondary to COVID-19. dexamethasone, vitamin-D, vitamin-C, respiratory care protocol oxygen as needed.  Ciprofloxacin was started for urinary tract infection pending urine cultures.  Rest of home medications reviewed and restarted.  Avoid any nephrotoxic agents.  Metformin held due to acute kidney injury gentle IV hydration.   She initially required high-flow nasal cannula and was able to taper back to nasal cannula.  CPAP continued for OSA. She has completed Remdesivir.  She is on a Decadron wean at time of discharge.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Urinary tract infection, Urine analysis abnormal, White blood cell count normal
Clinical narrative: Pt presents to the ED for fever and urinary frequency.  Symptoms have been going on for the past couple days.  She has also noticed shortness of breath and has required 4 L of oxygen in the ED.  Initial vital signs showed oxygen saturation of 85% on room air, T-max of a 100.2°.  Labs, WBC 7.05, creatinine of 2.2, CRP 13.7, D-dimer 620.  Virology - positive COVID-19.  UA was positive for urinary tract infection. Pt was diagnosed with acute hypoxic respiratory failure secondary to COVID-19. dexamethasone, vitamin-D, vitamin-C, respiratory care protocol oxygen as needed.  Ciprofloxacin was started for urinary tract infection pending urine cultures.  Rest of home medications reviewed and restarted.  Avoid any nephrotoxic agents.  Metformin held due to acute kidney injury gentle IV hydration.   She initially required high-flow nasal cannula and was able to taper back to nasal cannula.  CPAP continued for OSA. She has completed Remdesivir.  She is on a Decadron wean at time of discharge.
Age: 64.0
Sex: M
Vaccine: PNC20, TDAP, VARZOS
Symptoms: Dizziness, Headache, Pyrexia
Clinical narrative: Patient complaining of fever, headache and dizziness
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Nausea, Skin discolouration
Clinical narrative: Patient was vaccinated on 04/27/2022 at 4:30pm and began to experience symptoms (primarily joint pain) at 9AM on 04/28/2022. Symptoms included joint pain throughout entire body (mostly upper body), nausea, whiteness at fingertips, and overall progressive worsening up to time of reporting symptoms via phone call on 04/29/2022 around 10AM. There was no redness, no fevers, no chills, and no shortness of breath (patient denied all).
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Cough, Discomfort, Nasal congestion, Rhinorrhoea
Clinical narrative: Runny nose, coughing, sneezing, stuffy nose, with nasal pressure. Tested positive for Covid-19 4/9/22.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sneezing
Clinical narrative: Runny nose, coughing, sneezing, stuffy nose, with nasal pressure. Tested positive for Covid-19 4/9/22.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Disturbance in attention, Fatigue, Headache
Clinical narrative: Slightly sore arm General malaise feeling Sore, achy muscles Headache Chills Lethargic, lack of energy Tired Hard to concentrate; want to lie down and close my eyes
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Lethargy, Malaise, Myalgia, Pain, Pain in extremity
Clinical narrative: Slightly sore arm General malaise feeling Sore, achy muscles Headache Chills Lethargic, lack of energy Tired Hard to concentrate; want to lie down and close my eyes
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Immediate post-injection reaction, Unresponsive to stimuli
Clinical narrative: Patient became dizzy as soon as the vaccine was given. She had pulse and was breathing, but did not respond.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Atelectasis, COVID-19, Chest X-ray abnormal, Cough
Clinical narrative: Pt presented to the ER 12/5/2021 complaining of altered mentation, decreased appetite, weight loss of 20 lb over 1 month.  Patient also having urinary incontinence.  Patient had been refusing to eat.  Patient's husband present at bedside.  Husband and patient's son who both live with the patient are both positive for COVID-19.  He stated that patient has been getting worse over the last month complaining of generalized pain all the time.  He was unable to care for the patient so he called ER.  Patient also had a cough that been going on "for a while", at least 4 months.  Patient had been having increasing weakness.  On 12/11 Overnight patient developed hypoxia and needed 5 liters supplemental oxygen. CXR showed right perihilar and basilar atelactasis and increasing left lower love airspace disease with small left pleural effusion. She received decadron, Patient was having congestion, which is slowly getting better, which I hope will continue to get better as she recovers from COVID-19. She is on Mucinex DM and Claritin. Her oxygenation issues is resolved and now she is off supplemental oxygen and saturating in 90s on RA.  Due to complication from other chronic illnesses, pt passed away on 12/24/21
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Death, Decreased appetite, Diet refusal, Hypoxia, Lung disorder
Clinical narrative: Pt presented to the ER 12/5/2021 complaining of altered mentation, decreased appetite, weight loss of 20 lb over 1 month.  Patient also having urinary incontinence.  Patient had been refusing to eat.  Patient's husband present at bedside.  Husband and patient's son who both live with the patient are both positive for COVID-19.  He stated that patient has been getting worse over the last month complaining of generalized pain all the time.  He was unable to care for the patient so he called ER.  Patient also had a cough that been going on "for a while", at least 4 months.  Patient had been having increasing weakness.  On 12/11 Overnight patient developed hypoxia and needed 5 liters supplemental oxygen. CXR showed right perihilar and basilar atelactasis and increasing left lower love airspace disease with small left pleural effusion. She received decadron, Patient was having congestion, which is slowly getting better, which I hope will continue to get better as she recovers from COVID-19. She is on Mucinex DM and Claritin. Her oxygenation issues is resolved and now she is off supplemental oxygen and saturating in 90s on RA.  Due to complication from other chronic illnesses, pt passed away on 12/24/21
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Mental status changes, Pain, Pleural effusion, Respiratory tract congestion, Urinary incontinence
Clinical narrative: Pt presented to the ER 12/5/2021 complaining of altered mentation, decreased appetite, weight loss of 20 lb over 1 month.  Patient also having urinary incontinence.  Patient had been refusing to eat.  Patient's husband present at bedside.  Husband and patient's son who both live with the patient are both positive for COVID-19.  He stated that patient has been getting worse over the last month complaining of generalized pain all the time.  He was unable to care for the patient so he called ER.  Patient also had a cough that been going on "for a while", at least 4 months.  Patient had been having increasing weakness.  On 12/11 Overnight patient developed hypoxia and needed 5 liters supplemental oxygen. CXR showed right perihilar and basilar atelactasis and increasing left lower love airspace disease with small left pleural effusion. She received decadron, Patient was having congestion, which is slowly getting better, which I hope will continue to get better as she recovers from COVID-19. She is on Mucinex DM and Claritin. Her oxygenation issues is resolved and now she is off supplemental oxygen and saturating in 90s on RA.  Due to complication from other chronic illnesses, pt passed away on 12/24/21
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: Pt presented to the ER 12/5/2021 complaining of altered mentation, decreased appetite, weight loss of 20 lb over 1 month.  Patient also having urinary incontinence.  Patient had been refusing to eat.  Patient's husband present at bedside.  Husband and patient's son who both live with the patient are both positive for COVID-19.  He stated that patient has been getting worse over the last month complaining of generalized pain all the time.  He was unable to care for the patient so he called ER.  Patient also had a cough that been going on "for a while", at least 4 months.  Patient had been having increasing weakness.  On 12/11 Overnight patient developed hypoxia and needed 5 liters supplemental oxygen. CXR showed right perihilar and basilar atelactasis and increasing left lower love airspace disease with small left pleural effusion. She received decadron, Patient was having congestion, which is slowly getting better, which I hope will continue to get better as she recovers from COVID-19. She is on Mucinex DM and Claritin. Her oxygenation issues is resolved and now she is off supplemental oxygen and saturating in 90s on RA.  Due to complication from other chronic illnesses, pt passed away on 12/24/21
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Fever, shivering, nausea, headaches
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Chills, Discomfort, Fatigue, Headache
Clinical narrative: Summary:  rash, hair loss (general thinning and dime-sized distinct patch lost at front crown) extreme fatigue, hair loss and fatigue lasting over 3 months; fever, chills, body aches worse than any patient had experienced in over 10 years; reaction to shot 2 triggered flare in inflammatory bowel or endometriosis pain, inflammation around IUD requiring removal, ovarian cysts and pain.  Patient recorded menstrual cycle days and received booster on day 3 of menstrual cycle (based on studies showing hormonal role in vaccine seroconversion).  Patient was mandated to receive booster shot or be fired from her employment (graduate student instructor) and be unable to complete her doctoral degree (registration and enrollment hold and suspension).  Patient contacted primary care and OBGYN providers, COVID-19 advisory committee, and disability compliance office with concerns about side effects from second shot (previously reported).  Case was escalated to the Medical Director.  Dr. stated that the Office had removed the normal medical exception option for the COVID-19 vaccination and only a very narrow list of CDC reactions could quality for exemption.  Due to the failure of vaccine trials to adequately represent and record side effects common in women and people with auto-immune risk, doctors initially did not believe patient.  Patient suspected COVID-19 infection in March of 2020.  Patient requested nucleocapsid test to confirm seropositivity, but was denied and could not self-order test at any location (patient also contacted laboratory facilities).  Please see report of reaction to 2nd Pfizer dose in E report number 780379.  Given the threat to patient's livelihood and education, patient received Moderna booster after medical exemption requests were denied.  Patient developed a fever (normal is 97.6) that slowly rose until patient took ibuprofen at around 101.  Patient developed chills, body aches, head ache, restlessness, extreme pressure and pain in fingernails (like they were going to pop off), followed by extreme fatigue for over 3 months, left armpit lymph node swelling for over 2 weeks, rash on neck and under armpit that was unusual to patient, general hair thinning and loss of dime-sized patch of hair.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Onychalgia, Pain, Pyrexia, Rash
Clinical narrative: Summary:  rash, hair loss (general thinning and dime-sized distinct patch lost at front crown) extreme fatigue, hair loss and fatigue lasting over 3 months; fever, chills, body aches worse than any patient had experienced in over 10 years; reaction to shot 2 triggered flare in inflammatory bowel or endometriosis pain, inflammation around IUD requiring removal, ovarian cysts and pain.  Patient recorded menstrual cycle days and received booster on day 3 of menstrual cycle (based on studies showing hormonal role in vaccine seroconversion).  Patient was mandated to receive booster shot or be fired from her employment (graduate student instructor) and be unable to complete her doctoral degree (registration and enrollment hold and suspension).  Patient contacted primary care and OBGYN providers, COVID-19 advisory committee, and disability compliance office with concerns about side effects from second shot (previously reported).  Case was escalated to the Medical Director.  Dr. stated that the Office had removed the normal medical exception option for the COVID-19 vaccination and only a very narrow list of CDC reactions could quality for exemption.  Due to the failure of vaccine trials to adequately represent and record side effects common in women and people with auto-immune risk, doctors initially did not believe patient.  Patient suspected COVID-19 infection in March of 2020.  Patient requested nucleocapsid test to confirm seropositivity, but was denied and could not self-order test at any location (patient also contacted laboratory facilities).  Please see report of reaction to 2nd Pfizer dose in E report number 780379.  Given the threat to patient's livelihood and education, patient received Moderna booster after medical exemption requests were denied.  Patient developed a fever (normal is 97.6) that slowly rose until patient took ibuprofen at around 101.  Patient developed chills, body aches, head ache, restlessness, extreme pressure and pain in fingernails (like they were going to pop off), followed by extreme fatigue for over 3 months, left armpit lymph node swelling for over 2 weeks, rash on neck and under armpit that was unusual to patient, general hair thinning and loss of dime-sized patch of hair.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Restlessness
Clinical narrative: Summary:  rash, hair loss (general thinning and dime-sized distinct patch lost at front crown) extreme fatigue, hair loss and fatigue lasting over 3 months; fever, chills, body aches worse than any patient had experienced in over 10 years; reaction to shot 2 triggered flare in inflammatory bowel or endometriosis pain, inflammation around IUD requiring removal, ovarian cysts and pain.  Patient recorded menstrual cycle days and received booster on day 3 of menstrual cycle (based on studies showing hormonal role in vaccine seroconversion).  Patient was mandated to receive booster shot or be fired from her employment (graduate student instructor) and be unable to complete her doctoral degree (registration and enrollment hold and suspension).  Patient contacted primary care and OBGYN providers, COVID-19 advisory committee, and disability compliance office with concerns about side effects from second shot (previously reported).  Case was escalated to the Medical Director.  Dr. stated that the Office had removed the normal medical exception option for the COVID-19 vaccination and only a very narrow list of CDC reactions could quality for exemption.  Due to the failure of vaccine trials to adequately represent and record side effects common in women and people with auto-immune risk, doctors initially did not believe patient.  Patient suspected COVID-19 infection in March of 2020.  Patient requested nucleocapsid test to confirm seropositivity, but was denied and could not self-order test at any location (patient also contacted laboratory facilities).  Please see report of reaction to 2nd Pfizer dose in E report number 780379.  Given the threat to patient's livelihood and education, patient received Moderna booster after medical exemption requests were denied.  Patient developed a fever (normal is 97.6) that slowly rose until patient took ibuprofen at around 101.  Patient developed chills, body aches, head ache, restlessness, extreme pressure and pain in fingernails (like they were going to pop off), followed by extreme fatigue for over 3 months, left armpit lymph node swelling for over 2 weeks, rash on neck and under armpit that was unusual to patient, general hair thinning and loss of dime-sized patch of hair.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Crying, Fatigue, Fear, Loss of consciousness, Pain of skin
Clinical narrative: Approx 24 hours after my second COVID vaccination, I can only describe it as the skin on my entire body became intensely painfully, to the point where it made me cry until I passed out from exhaustion. This went on for about 24 hours. My arm around the vaccine site was also burning hot and extremely sensitive. On 01/12/2022, four days after the vaccine, I woke up with horrible hives that started around the vaccine site on my left arm, and eventually covered both arms and both legs. The hives were swollen and very itchy. I self- treated with benedryl tablets (oral) and hydrocortisone cream (topical), because I do not have medical insurance or money for a doctor. The hives lasted approximately one week.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Swelling, Urticaria, Vaccination site hypersensitivity, Vaccination site pain
Clinical narrative: Approx 24 hours after my second COVID vaccination, I can only describe it as the skin on my entire body became intensely painfully, to the point where it made me cry until I passed out from exhaustion. This went on for about 24 hours. My arm around the vaccine site was also burning hot and extremely sensitive. On 01/12/2022, four days after the vaccine, I woke up with horrible hives that started around the vaccine site on my left arm, and eventually covered both arms and both legs. The hives were swollen and very itchy. I self- treated with benedryl tablets (oral) and hydrocortisone cream (topical), because I do not have medical insurance or money for a doctor. The hives lasted approximately one week.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site urticaria, Vaccination site warmth
Clinical narrative: Approx 24 hours after my second COVID vaccination, I can only describe it as the skin on my entire body became intensely painfully, to the point where it made me cry until I passed out from exhaustion. This went on for about 24 hours. My arm around the vaccine site was also burning hot and extremely sensitive. On 01/12/2022, four days after the vaccine, I woke up with horrible hives that started around the vaccine site on my left arm, and eventually covered both arms and both legs. The hives were swollen and very itchy. I self- treated with benedryl tablets (oral) and hydrocortisone cream (topical), because I do not have medical insurance or money for a doctor. The hives lasted approximately one week.
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Product administered to patient of inappropriate age
Clinical narrative: Patient received the 3rd dose of Pfizer but was not eligible due to age restriction.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Nasopharyngitis, Oropharyngeal pain, Respiratory tract infection
Clinical narrative: My cold became much worse and lasted several weeks. Sinus infection, congestion, cough and sore throat.  I tested positive for Covid on 04/26/2022. My symptoms were similar to the cold I had, at first I thought it was just a relapse of my cold but wasn't as bad! Each day after the initial onset it was better. I am almost symptom free now, 04/29/2022.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sinusitis
Clinical narrative: My cold became much worse and lasted several weeks. Sinus infection, congestion, cough and sore throat.  I tested positive for Covid on 04/26/2022. My symptoms were similar to the cold I had, at first I thought it was just a relapse of my cold but wasn't as bad! Each day after the initial onset it was better. I am almost symptom free now, 04/29/2022.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Feeling cold, Headache, Nervousness
Clinical narrative: 2 hours after the vaccine the patients arm started hurting really bad.  She felt dizzy and super chilled and cold.  Then she felt shaky with a bad headache.  She had a fever over 100 degrees.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: 2 hours after the vaccine the patients arm started hurting really bad.  She felt dizzy and super chilled and cold.  Then she felt shaky with a bad headache.  She had a fever over 100 degrees.
Sex: U
Vaccine: COVID19
Symptoms: Death
Clinical narrative: My mother passed away after getting this treatment
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Pain in extremity
Clinical narrative: Right side of my neck and arm  excruciating pain for over a month see medical records at Hospital
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Deep vein thrombosis, Laboratory test, Limb discomfort, Musculoskeletal discomfort, Ultrasound scan
Clinical narrative: After a long drive g trip and subsequent calf and knee discomfort, I was diagnosed with a popliteal deep vein thrombosis in my left knee.  They determined that the clot had been there a while and had already begun to recanalize at the time of the diagnosis.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: X-ray limb
Clinical narrative: After a long drive g trip and subsequent calf and knee discomfort, I was diagnosed with a popliteal deep vein thrombosis in my left knee.  They determined that the clot had been there a while and had already begun to recanalize at the time of the diagnosis.
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Joint swelling, Loss of personal independence in daily activities, Pain in jaw, Temporomandibular joint syndrome, Trismus
Clinical narrative: My left jaw became very sore and the joint swelled to the point of being unable to chew, and my jaw was out of alignment so that my teeth couldnt meet.  I had only liquid or soft foods for the first few days.    After icing and ibuprofen for about 4 days I was able to eat solid foods again, and it gradually subsided and was resolved after about 7 days total.   I have never had TMJ before and still dont know why this happened.  The only thing different was the Shingrix vaccine I had gotten.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Fatigue, Influenza like illness, Night sweats, Pain, Pyrexia
Clinical narrative: Fever for 1 week, aches since injection, fatigue, flu-like symptoms,  horrible night sweats,
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: DIARRHEA; This spontaneous report received from a patient concerned an 8 decade old female of an unspecified race and ethnicity. The patient's height, and weight were not reported. The patient's concurrent conditions included: stomach issues. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 1805018, expiry: UNKNOWN) dose was not reported, 1 total administered on 08-MAR-2021 in right arm for prophylactic vaccination. On 08-MAR-2021, following vaccination with first dose of covid-19 vaccine ad26.cov2.s, the patient experienced headache, cramps, sore arm, dizzy, aches (Dose number in series 1). On 09-MAR-2021, the patient experienced diarrhea and stomach cramps (Dose number in series 1). The patient recovered from headache, cramps, dizzy, aches on 09-MAR-2021 and sore arm on 12-MAR-2021 and not recovered from diarrhea and stomach cramps. The patient additionally received covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: Unknown, expiry: Unknown) dose, start therapy date were not reported, 1 total for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, following vaccination with booster dose of covid-19 vaccine ad26.cov2.s, the patient experienced diarrhea (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of diarrhea was not reported. This report was non-serious. This case, involving the same patient is linked to 20210347282 (Dose number in series 1).
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac disorder, Cardiac operation, Catheterisation cardiac abnormal, Chest pain, Computerised tomogram thorax
Clinical narrative: 3 days after administration I was having severe chest pains across my chest. I was rushed into a local Hospital to find out I was having a heart attack due to a blood clot in my heart. I have never in my life ever had a blood clot or have had a heart attack. I was hurried into surgery and needed 4 stints placed into my right heart valve. I have had a heart complications and kidney complications ever since.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Coronary arterial stent insertion, Coronary artery thrombosis, Echocardiogram, Myocardial infarction, Renal disorder
Clinical narrative: 3 days after administration I was having severe chest pains across my chest. I was rushed into a local Hospital to find out I was having a heart attack due to a blood clot in my heart. I have never in my life ever had a blood clot or have had a heart attack. I was hurried into surgery and needed 4 stints placed into my right heart valve. I have had a heart complications and kidney complications ever since.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: tested positive for covid; tested positive for covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 42-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 03Mar2021 as dose 1, single (Lot number: EN6203), in left arm, on 25Mar2021 as dose 2, single (Lot number: EL3248), in left arm and on 23Nov2021 as dose 3 (booster), single (Lot number: FJ1620) at the age of 42 years, in left arm, all intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. No covid prior vaccination. Other vaccine in four weeks: Unknown.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 26Apr2022, outcome "not recovered" and all described as "tested positive for covid". The event "tested positive for covid" required physician office visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (26Apr2022) Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Patient reports he experienced tinnitis in his ears beginning 2 days after his first Covid-19 Pfizer vaccine. He did not seek medical attention or advice but states he reported the side effect online. He received his second Covid-19 Pfizer vaccine 3 weeks later and did not experience worsening of tinnitis at the time.  He states the ringing has gotten milder but is still noticeable.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Pneumonia, Swelling, Swelling face
Clinical narrative: Nov 14, 2021 - face swelling. fatigue Nov 17, 2021 - difficulty breathing, cough, headache, body aches, chills, swollen/achey joints, stomach pain, extreme fatigue, metallic taste in mouth
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Arthralgia, Chest X-ray, Chills, Cough
Clinical narrative: Nov 14, 2021 - face swelling. fatigue Nov 17, 2021 - difficulty breathing, cough, headache, body aches, chills, swollen/achey joints, stomach pain, extreme fatigue, metallic taste in mouth
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Dyspnoea, Fatigue, Headache, Joint swelling
Clinical narrative: Nov 14, 2021 - face swelling. fatigue Nov 17, 2021 - difficulty breathing, cough, headache, body aches, chills, swollen/achey joints, stomach pain, extreme fatigue, metallic taste in mouth
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, SARS-CoV-2 antibody test positive, Swelling face
Clinical narrative: Nov 14, 2021 - face swelling. fatigue Nov 17, 2021 - difficulty breathing, cough, headache, body aches, chills, swollen/achey joints, stomach pain, extreme fatigue, metallic taste in mouth
Age: 91.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, COVID-19, Cough, Dyspnoea, Pyrexia
Clinical narrative: Pt presented the ER with complaints of cough and shortness of breath. In the ER she was febrile with T-max of 100.5°, chest x-ray did not show any focal infiltrates, CRP/procalcitonin were elevated, COVID-19 PCR came back positive.  Troponin was elevated.  Patient was started on Decadron and was admitted to hospitalist service.  Pt remained on 2 L home oxygen. Her symptoms improved, remained afebrile.  She will be discharged in stable condition to home
Age: 91.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Pt presented the ER with complaints of cough and shortness of breath. In the ER she was febrile with T-max of 100.5°, chest x-ray did not show any focal infiltrates, CRP/procalcitonin were elevated, COVID-19 PCR came back positive.  Troponin was elevated.  Patient was started on Decadron and was admitted to hospitalist service.  Pt remained on 2 L home oxygen. Her symptoms improved, remained afebrile.  She will be discharged in stable condition to home
Age: 91.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature increased, C-reactive protein increased, COVID-19, Chest X-ray normal, Cough
Clinical narrative: Pt presented the ER with complaints of cough and shortness of breath. In the ER she was febrile with T-max of 100.5°, chest x-ray did not show any focal infiltrates, CRP/procalcitonin were elevated, COVID-19 PCR came back positive.  Troponin was elevated.  Patient was started on Decadron and was admitted to hospitalist service.  Pt remained on 2 L home oxygen. Her symptoms improved, remained afebrile.  She will be discharged in stable condition to home
Age: 91.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Procalcitonin increased, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Pt presented the ER with complaints of cough and shortness of breath. In the ER she was febrile with T-max of 100.5°, chest x-ray did not show any focal infiltrates, CRP/procalcitonin were elevated, COVID-19 PCR came back positive.  Troponin was elevated.  Patient was started on Decadron and was admitted to hospitalist service.  Pt remained on 2 L home oxygen. Her symptoms improved, remained afebrile.  She will be discharged in stable condition to home